Mitchell P. Kopin 13D and 13G filings for Caladrius Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-22 06:11 am Purchase |
2021-02-12 | 13G | Caladrius Biosciences, Inc. CLBS |
Mitchell P. Kopin | 63,307 1.600% |
63,307 (New Position) |
Filing |